Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Treasury Shares (2020 - 2026)

Journey Medical filings provide 6 years of Treasury Shares readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 21.02% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 21.02% decrease, with the full-year FY2025 number at $1.8 million, down 21.02% from a year prior.
  • Treasury Shares hit $1.8 million in Q4 2025 for Journey Medical, down from $1.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.7 million in Q2 2024 to a low of $708524.0 in Q3 2021.
  • Median Treasury Shares over the past 5 years was $1.9 million (2023), compared with a mean of $1.8 million.
  • Biggest five-year swings in Treasury Shares: surged 238.96% in 2022 and later crashed 43.13% in 2023.
  • Journey Medical's Treasury Shares stood at $715030.0 in 2021, then soared by 216.22% to $2.3 million in 2022, then crashed by 42.2% to $1.3 million in 2023, then soared by 79.04% to $2.3 million in 2024, then dropped by 21.02% to $1.8 million in 2025.
  • The last three reported values for Treasury Shares were $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.